Remote control module for adjustable implants

US12213708B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12213708-B2
Application numberUS-202117405663-A
CountryUS
Kind codeB2
Filing dateAug 18, 2021
Priority dateSep 8, 2020
Publication dateFeb 4, 2025
Grant dateFeb 4, 2025

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present disclosure broadly provides applications of communication at ultrasound frequencies to establish transcutaneous data communication between medical devices located on and/or within a body of a patient, including inter alia: features for adjustable implants including data communication, hermetic containment, and torque amplification features.

First claim

Opening claim text (preview).

What is claimed is: 1. A deformity treatment system, comprising: a control module having a transceiver configured to send and receive data; and an adjustable implant, the adjustable implant includes a driver configured to adjust the adjustable implant; wherein the adjustable implant includes a first magnetic element; wherein the control module is implantable separately from the adjustable implant and includes a second magnetic element; and wherein the adjustable implant is adjusted in accordance with treatment instructions using a magnetic field generated from the second magnetic element in the control module to move the first magnetic element in the adjustable implant. 2. The system of claim 1 , wherein the driver includes the first magnetic element. 3. The system of claim 2 , wherein the driver includes an actuator configured to rotate the magnetic element. 4. The system of claim 3 , wherein the first magnetic element includes a rotatable permanent magnet. 5. The system of claim 3 , wherein the actuator includes an electric motor. 6. The system of claim 1 , wherein the transceiver includes an ultrasonic transducer configured to send and receive ultrasound signals. 7. The system of claim 1 , further comprising: a controller operably connected to one or more of the transceiver and the driver. 8. The system of claim 7 , wherein the controller includes a microcontroller. 9. The system of claim 1 , wherein the control module is configured for subcutaneous placement within a body of a patient. 10. The system of claim 1 , wherein the control module is configured to be secured to a bone of a patient. 11. A system for treating a deformity, comprising: an adjustable implant; a control module implantable separately from the adjustable implant, the control module having a magnetic element; and an external transceiver; wherein the adjustable implant includes a rotatable permanent magnet, wherein the rotatable permanent magnet of the adjustable implant is configured to magnetically couple with the magnetic element of the control module, wherein the external transceiver is configured to transmit treatment instructions to the control module, and wherein the control module is configured to adjust the adjustable implant in accordance with the treatment instructions, and wherein rotation of the rotatable permanent magnet is configured to change a dimension of the adjustable implant. 12. The system of claim 11 , wherein the control module includes: a transceiver configured to communicate with the external transceiver; and a driver configured to adjust an adjustable implant. 13. The system of claim 12 , wherein the driver includes an actuator configured to rotate the rotatable permanent magnet of the adjustable implant. 14. The system of claim 11 , wherein the external transceiver is configured to communication with the control module using an ultrasound signal. 15. The system of claim 11 , wherein the external transceiver is configured to communicate with the control module using a radio frequency signal. 16. The system of claim 11 , wherein the control module is configured to determine an amount of adjustment of the adjustable implant and communicate the amount of adjustment to the external transceiver. 17. The system of claim 11 , wherein the control module is configured for subcutaneous placement and configured to be secured to a bone of a patient. 18. A method for treating a deformity, comprising: providing an adjustable implant within an intramedullary cavity of a bone, wherein the adjustable implant includes a first magnetic element; securing a control module to the bone, the control module being implanted separately from the adjustable implant and having a second magnetic element; and communicating treatment instructions to the control module using an external transceiver; and adjusting the adjustable implant in accordance with the treatment instructions using a magnetic field generated from the second magnetic element in the control module to move the first magnetic element in the adjustable implant.

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12213708B2 cover?
The present disclosure broadly provides applications of communication at ultrasound frequencies to establish transcutaneous data communication between medical devices located on and/or within a body of a patient, including inter alia: features for adjustable implants including data communication, hermetic containment, and torque amplification features.
Who is the assignee on this patent?
Nuvasive Specialized Orthopedics Inc
What technology area does this patent fall under?
Primary CPC classification A61B17/7216. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Feb 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 9 related publications on this page (citations in our corpus or others sharing the same primary CPC).